Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-10-01Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in ratsPharmacology Biochemistry and Behavior · 2026-10-01Stroboscopic light stimulation as a controllable probe of the psilocybin state: a mechanistic framework and a falsifiable predictionFrontiers in Pharmacology · 2026-09-30ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted TherapyClinicalTrials.gov · 2026-09-22A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility TrialClinicalTrials.gov · 2026-09-09Psilocybin-induced changes in electroencephalography link acute and long-term effects.Journal of psychopharmacology (Oxford, England) · 2026-09-04Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's DiseaseClinicalTrials.gov · 2026-09-04CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-09-01An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.Molecular psychiatry · 2026-08-04Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.Journal of pain and symptom management · 2026-08-03The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-22Surprising Variability in Tryptamine Profiles of Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions.Journal of fungi (Basel, Switzerland) · 2026-07-02Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsClinicalTrials.gov · 2026-07-01Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEWInternational Journal of Innovative Technologies in Social Science · 2026-06-24Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developmentsJournal of Psychedelic Studies · 2026-06-12Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-06-04Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-06-01Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education, Health and Sport · 2026-05-07Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Effects of a single dose of psilocybin on diet-induced weight loss in obese miceTranslational Psychiatry · 2026-04-14Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in ratsJournal of Neurophysiology · 2026-04-01Psychedelic Experiences and Finitude in Serious Illness: A Qualitative SynthesisJournal of Pain and Symptom Management · 2026-03-26Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept StudyClinicalTrials.gov · 2026-03-11A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.ClinicalTrials.gov · 2026-03-03Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-03-01India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics.Indian journal of psychological medicine · 2026-02-05Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb PainClinicalTrials.gov · 2026-01-09Associations of Couples' Psychedelic Use with Shared Reality and Relational Well-Being.Journal of psychoactive drugs · 2026-01-06Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-02Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic studyNeuroscience Applied · 2026-01-01Preclinical evaluation of psilocybin as an anti-inflammatory agentNeuroscience Applied · 2026-01-01Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybinNeuroscience Applied · 2026-01-01Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic RetreatPsyArXiv · 2025-12-31Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic PsychedelicsSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-12-01Between enhancement and risk: A critical review of psychedelic microdosing.Current opinion in psychology · 2025-12-01Concomitant use of antidepressants and classic psychedelics: A scoping review.Journal of psychopharmacology (Oxford, England) · 2025-10-01Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.Journal of psychopharmacology (Oxford, England) · 2025-09-01Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and RatsBiological Psychiatry Global Open Science · 2025-09-01Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.Medical science monitor: international medical journal of experimental and clinical research · 2025-08-09Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-07-13Mycelium Growth and Development of spp. Mother Cultures on Agar-Based Media.Journal of fungi (Basel, Switzerland) · 2025-06-13Psychedelics in the treatment of cluster headachesKlinická farmakologie a farmacie · 2025-04-29[Treatment with psychedelics: potential benefits in Parkinson's disease].Revue medicale suisse · 2025-04-23Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.BMJ open · 2025-04-15Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disordersEuropean Psychiatry · 2025-04-01The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report.Journal of Parkinson's disease · 2025-03-01Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons.Journal of neurochemistry · 2025-03-01Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related EffectsDrug and Alcohol Dependence · 2025-02-01Exploring Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps.Journal of fungi (Basel, Switzerland) · 2025-01-28Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?International review of neurobiology · 2025-01-01What fMRI studies say about the nature of the psychedelic effect: a scoping review.Frontiers in neuroscience · 2025-01-01Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.Scientific reports · 2024-12-31Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.The European journal of neuroscience · 2024-11-01The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapyPsyArXiv · 2024-05-17Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.Journal of psychopharmacology (Oxford, England) · 2024-05-01Psychedelics and the 'inner healer': Myth or mechanism?Journal of psychopharmacology (Oxford, England) · 2024-05-01Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortexAuthorea Preprints · 2024-04-22Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".Frontiers in psychiatry · 2024-01-01Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledgeJournal of Education Health and Sport · 2023-12-30Flies on ’Shrooms: Studying the Psychotherapeutic Potential of Psilocybin using DrosophilaAmerican Entomologist · 2023-12-01A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.Biotechnology advances · 2023-12-01Potential use of psilocybin drugs in the treatment of depression.Expert opinion on emerging drugs · 2023-12-01MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICSIBRO Neuroscience Reports · 2023-10-01DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?IBRO Neuroscience Reports · 2023-10-01CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANSIBRO Neuroscience Reports · 2023-10-01HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.Journal of pain and symptom management · 2023-09-01Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2023-09-01Psilocybin for the treatment of anorexia nervosa.Nature medicine · 2023-08-01Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in ratsFrontiers in Neuroscience · 2023-06-22Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measuresNeuroscience Applied · 2023-01-01Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvementNeuroscience Applied · 2023-01-01Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study.Frontiers in psychiatry · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of personalized medicine · 2022-06-19The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in ratsNeuroscience Applied · 2022-01-01Rats hallucinate in a similar manner to humans after psilocinNeuroscience Applied · 2022-01-01Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience applied · 2022-01-01P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-12-01P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in ratsEuropean Neuropsychopharmacology · 2021-12-01P.0858 Psilocin induces perceptual alterations in rats: visual discrimination studyEuropean Neuropsychopharmacology · 2021-12-01Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validityTranslational Psychiatry · 2021-10-02Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug AnalysisCurrent Addiction Reports · 2021-07-26Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-03Modulatory effects of ayahuasca on personality structure in a traditional framework.Psychopharmacology · 2020-10-01A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2020-04-01The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.Frontiers in pharmacology · 2020-01-01P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personalityEuropean Neuropsychopharmacology · 2019-12-01Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom.ACS chemical biology · 2018-12-21Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar ratsBehavioural Pharmacology · 2018-09-01Psychopharmacology of Psilocybin in Cancer PatientsClinicalTrials.gov · 2018-07-19Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.Psychopharmacology · 2018-02-01Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-02-01Taking Psychedelics Seriously (TH316)Journal of Pain and Symptom Management · 2018-01-31[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG studyEuropean Neuropsychopharmacology · 2016-10-01Sex differences and serotonergic mechanisms in the behavioural effects of psilocinBehavioural Pharmacology · 2016-06-01PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe International Journal of Neuropsychopharmacology · 2016-05-26On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe1Economic Botany · 2016-05-10The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the RatFrontiers in Behavioral Neuroscience · 2014-05-16Psilocybin--summary of knowledge and new perspectives.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2014-03-01P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocinEuropean Neuropsychopharmacology · 2014-03-01EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatmentEuropean Psychiatry · 2013-12-31Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British journal of psychiatry: the journal of mental science · 2012-03-01Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.Journal of psychopharmacology (Oxford, England) · 2011-11-01Iconography in Bradshaw rock art: breaking the circularity.Clinical & experimental optometry · 2011-09-01Psilocin multiple intake resulted and in cardiotoxic effectsActa Toxicologica · 2006-01-01Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushroomsActa Toxicologica · 2003-01-01Listening for the logos: a study of reports of audible voices at high doses of psilocybinMedical Entomology and Zoology · 1996-01-01幻覚剤に関する研究-5-Psilocybinの合成(ノ-ト)Medical Entomology and Zoology · 1974-11-01精神分裂病者の病像とPsilocybin,LSD-25反応に関する精神病理学的研究Medical Entomology and Zoology · 1972-10-01催幻覚薬に関する薬理学的研究(第3報):第1篇 Psilocybinの文献的考察ことに中枢作用についてMedical Entomology and Zoology · 1968-01-01Drugs and phantasy: the effects of LSD, psilocybin, and sernyl on college studentsMedical Entomology and Zoology · 1965-01-01